Press Releases

Achieve Life Sciences, Inc. a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline for treatment of nicotine dependence, today announced that the U.S. Food and Drug Administration (FDA) has accepted the cytisinicline New Drug Application (NDA) for a new treatment for smoking cessation in adults. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) targeted action date of June 20, 2026. “The FDA&rsquo

Advanced Pharmaceutical Manufacturing (APM), an emerging leader in drug production technologies, has announced the establishment of a new state-of-the-art manufacturing facility in Singapore. This cutting-edge facility is set to transform the local pharmaceutical landscape by significantly increasing production capacity and improving operational efficiencies.The decision to expand operations comes on the heels of rising demand for both generic and specialty pharmaceuticals in the Asia-

In a groundbreaking announcement, PharmaLink, a leader in pharmaceutical logistics and supply chain solutions, and BioMed Innovations, a pioneering contract research organization (CRO), have unveiled a strategic partnership aimed at enhancing research and development (R&D) capabilities in the pharmaceutical sector. This collaboration seeks to leverage each company’s strengths to create a more integrated and efficient drug development process.The partnership focuses on combining Pharm

A partnership aimed at transforming cold chain distribution solutions for the pharmaceutical industry has been announced. This collaboration between two industry leaders is set to leverage both organizations' strengths in supply chain management and temperature-controlled logistics.As the pharmaceutical industry continues to grow, the demand for effective cold chain solutions has become increasingly critical. This partnership seeks to address the challenges faced in transporting temper

In a significant move to bolster its research and development (R&D) capabilities, a leading pharmaceutical company has announced the opening of a state-of-the-art analytical laboratory in Singapore. This facility is expected to play a crucial role in the company’s innovation cycle, allowing for more advanced testing and analysis of new drug formulations. The new laboratory is equipped with the latest analytical instruments and technologies, allowing scientists and researchers to cond

The demand for efficient and effective clinical trial management in Southeast Asia has led to the establishment of a new partnership between two leading Contract Research Organizations (CROs). This joint venture is designed to enhance the operational capabilities and efficiency of clinical trials across the region, responding to the growing needs of pharmaceutical companies looking to expedite their drug development processes.This collaboration will leverage the extensive expertise and

The pharmaceutical industry in Asia is on the brink of a transformative growth phase, and today marks a significant milestone with the inauguration of a new innovative manufacturing facility in Singapore. This facility is built to meet the surging demand for pharmaceutical products across the region, showcasing cutting-edge technology that emphasizes efficiency and scalability.As the Asia-Pacific markets expand, the necessity for local production capabilities has never been more critic

Shionogi & Co., Ltd. announced the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) from Shionogi Inc., a New Jersey-based subsidiary of Shionogi, for ensitrelvir (Generic name: ensitrelvir fumaric acid, Code No.: S-217622), an investigational oral antiviral for the prevention of COVID-19 following exposure to an infected individual. The FDA has set an action date of June 16, 2026 under the Prescription Drug User Fee Act (PDUFA).

Neurophet (Co-CEOs Jake Junkil Been and Donghyeon Kim), an artificial intelligence (AI) solution company for brain disorders diagnosis and treatment, announced today that it has signed a Memorandum of Understanding (MoU) with the International Registry for Alzheimer's Disease and Other Dementias Foundation (InRAD) to accelerate global standardization of Alzheimer's and dementia-related data. Through this agreement, Neurophet and InRAD aim to strengthen their collaboration to

In a landmark development for the pharmaceutical research landscape, a prominent Contract Research Organization (CRO) based in India, MedResearch Innovations, has announced a strategic partnership with EuroPharma Solutions, a leading pharmaceutical company headquartered in Germany. The partnership aims at streamlining clinical trial processes and enhancing drug development timelines through innovative research methodologies and shared resources.This collaboration is particularly timely